Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -26.43%4.17M | -12.53%5.67M | -31.86%6.48M | -24.35%9.51M | 39.23%12.57M | 27.10%9.03M | 87.52%7.1M | -59.30%3.79M | 0.07%9.31M | 9.3M |
| Cost of revenue | -20.43%1.33M | -33.93%1.67M | -23.44%2.53M | -23.29%3.3M | 9.14%4.3M | 2.61%3.94M | 78.80%3.84M | -56.87%2.15M | 29.33%4.98M | 3.85M |
| Gross profit | -28.93%2.84M | 1.13%4M | -36.33%3.95M | -24.90%6.21M | 62.53%8.27M | 55.91%5.09M | 98.93%3.26M | -62.10%1.64M | -20.59%4.33M | 5.45M |
| Operating expense | -3.66%4.24M | -8.08%4.4M | -8.84%4.79M | -36.55%5.25M | 43.78%8.27M | -1.93%5.76M | 21.77%5.87M | 75.01%4.82M | -20.55%2.75M | 3.47M |
| Selling and administrative expenses | -3.66%4.24M | -8.20%4.4M | -8.71%4.79M | -37.05%5.25M | 44.94%8.34M | -1.93%5.76M | 21.77%5.87M | 75.01%4.82M | -20.55%2.75M | --3.47M |
| -General and administrative expense | -3.66%4.24M | -8.20%4.4M | -8.71%4.79M | -37.05%5.25M | 44.94%8.34M | -1.93%5.76M | 21.77%5.87M | 75.01%4.82M | -20.55%2.75M | --3.47M |
| Other operating expenses | ---- | -738.16%-55.31K | ---6.6K | ---- | ---66.68K | ---- | ---- | ---- | ---- | ---- |
| Total other operating income | ---- | 1,146.40%1.56K | --125 | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Operating profit | -248.38%-1.4M | 51.83%-401K | -186.70%-832.4K | 19,524.30%960.14K | 99.26%-4.94K | 74.39%-667K | 18.06%-2.6M | -301.78%-3.18M | -20.67%1.58M | 1.99M |
| Net non-operating interest income (expenses) | -14.29%-144K | -37.78%-126K | -7.20%-91.45K | 70.59%-85.31K | -27.21%-290.05K | 10.67%-228K | -65.75%-255.24K | -54.01%-154K | 0.17%-99.99K | -100.16K |
| Non-operating interest income | ---- | 8.36%10.83K | -47.51%10K | -41.87%19.04K | --32.76K | ---- | 28.50%17.01K | 29.66%13.24K | 22.43%10.21K | --8.34K |
| Non-operating interest expense | 14.29%144K | 24.20%126K | -2.78%101.45K | -67.67%104.35K | 41.58%322.81K | -16.26%228K | 62.80%272.26K | 51.75%167.24K | 1.57%110.2K | --108.5K |
| Net investment income | -95.25%2.11K | 469.35%44.36K | 7.79K | -75.98%1.39K | 182.91%5.79K | -62.99%2.05K | 5.53K | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 84.71%140.08K | -90.47%75.84K | 1,066.74%796.17K | 68.24K | 113.59%74.88K | -414.31%-551.12K | 175.34K | 0 | ||
| Less:Other special charges | ---- | -655.11%-3.77K | 99.89%-499 | -10,822.84%-444.78K | ---4.07K | ---- | ---- | -308.96%-18.94K | ---4.63K | ---- |
| Less:Write off | ---- | -80.94%-136.31K | 78.56%-75.34K | -447.62%-351.39K | ---64.17K | ---- | -113.13%-74.88K | 433.94%570.06K | ---170.71K | ---- |
| Other non-operating income (expenses) | 12.38%236K | 210K | -99.95%164 | 82.47%317.49K | 852.33%174K | 24.11%18.27K | 14.72K | |||
| Income before tax | -311.67%-1.31M | 60.56%-317K | -147.87%-803.66K | 1,538.92%1.68M | 114.21%102.44K | 73.93%-721K | 28.42%-2.77M | -333.76%-3.86M | -12.61%1.65M | 1.89M |
| Income tax | 1,246.67%202K | -67.84%15K | 3,789.91%46.64K | -98.56%1.2K | 83.16K | 0 | -25.72%5.42K | -98.49%7.3K | -2.01%484.18K | 494.09K |
| Net income | -353.92%-1.51M | 60.95%-332K | -150.68%-850.3K | 8,602.09%1.68M | 102.67%19.28K | 73.98%-721K | 28.41%-2.77M | -431.24%-3.87M | -16.36%1.17M | 1.4M |
| Net income continuous operations | -353.92%-1.51M | 60.95%-332K | -150.68%-850.3K | 8,602.09%1.68M | 102.67%19.28K | 73.98%-721K | 28.41%-2.77M | -431.24%-3.87M | -16.36%1.17M | --1.4M |
| Noncontrolling interests | -100.00%-16K | -8K | 0 | |||||||
| Net income attributable to the company | -360.19%-1.49M | 61.90%-324K | -150.68%-850.3K | 8,602.09%1.68M | 102.67%19.28K | 73.98%-721K | 28.41%-2.77M | -431.24%-3.87M | -16.36%1.17M | 1.4M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -360.19%-1.49M | 61.90%-324K | -150.68%-850.3K | 8,602.09%1.68M | 102.67%19.28K | 73.98%-721K | 28.41%-2.77M | -431.24%-3.87M | -16.36%1.17M | 1.4M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -346.15%-0.0058 | 60.61%-0.0013 | -150.77%-0.0033 | 6,400.00%0.0065 | 102.70%0.0001 | 65.74%-0.0037 | 46.27%-0.0108 | -546.67%-0.0201 | -37.76%0.0045 | 0.0072 |
| Diluted earnings per share | -346.15%-0.0058 | 60.61%-0.0013 | -150.77%-0.0033 | 6,400.00%0.0065 | 102.70%0.0001 | 65.74%-0.0037 | 46.27%-0.0108 | -546.67%-0.0201 | -37.76%0.0045 | 0.0072 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.